Cullinan Associates’s Walgreens Boots Alliance WBA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-11,359
Closed -$424K 275
2022
Q4
$424K Buy
+11,359
New +$427K 0.02% 214
2022
Q1
Sell
-3,845
Closed -$201K 248
2021
Q4
$201K Buy
+3,845
New +$186K 0.01% 230
2014
Q4
Sell
-23,440
Closed -$1.39M 92
2014
Q3
$1.39M Buy
23,440
+12,940
+123% +$849K 0.16% 73
2014
Q2
$464K Sell
10,500
-13,933
-57% -$973K 0.08% 76
2014
Q1
$1.61M Buy
24,433
+8,602
+54% +$541K 0.18% 65
2013
Q4
$909K Buy
15,831
+2,903
+22% +$169K 0.11% 75
2013
Q3
$695K Sell
12,928
-2,200
-15% -$111K 0.09% 80
2013
Q2
$669K Buy
+15,128
New +$737K 0.09% 79

Other funds holding WBA

Cullinan Associates's WBA Position: Q1 2023 in Review

Cullinan Associates sold out of Walgreens Boots Alliance (WBA) in Q1 2023, closing a stake of 11,359 shares — an estimated $424K sold.

Cullinan Associates first reported a position in WBA in Q2 2013 and held it in 8 quarters. The position peaked at $1.61M in Q1 2014. 1,236 funds tracked by Wall St. Rank hold WBA as of Q1 2023.

  • Cullinan Associates reported no remaining Walgreens Boots Alliance position as of Q1 2023 after selling out during the quarter.
  • Cullinan Associates sold 11,359 Walgreens Boots Alliance shares in Q1 2023, an estimated $424K.
  • Cullinan Associates first reported a position in Walgreens Boots Alliance in Q2 2013 and held it in 8 quarters.
  • Cullinan Associates's Walgreens Boots Alliance position peaked at $1.61M in Q1 2014.
  • 1,236 funds tracked by Wall St. Rank held Walgreens Boots Alliance as of Q1 2023.

Based on Cullinan Associates's 13F filing for Q1 2023, filed 5 Apr 2023.